High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.

In 29 chemotherapy-naive patients with stage II-III breast cancer, peripheral blood stem cells (PBSCs) were mobilised following fluorouracil 500 mg m-2, epirubicin 90-120 mg m-2 and cyclophosphamide 500 mg m-2 (FEC) and granulocyte colony-stimulating factor (G-CSF; Filgrastim) 300 microgram s.c. dai...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Wall, E., Nooijen, W. J., Baars, J. W., Holtkamp, M. J., Schorangel, J. H., Richel, D. J., Rutgers, E. J., Slaper-Cortenbach, I. C., van der Schoot, C. E., Rodenhuis, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033734/
https://www.ncbi.nlm.nih.gov/pubmed/7536025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033734/
https://www.ncbi.nlm.nih.gov/pubmed/7536025

Ejemplares similares